Ad
Adicet (Regeneron)
Redwood City CAFounded 2014100 employees
Private CapbiotechAcquiredOncology
Platform: γδ T Cell
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ADI-7213 | ADI-7213 | Phase 2/3 | 2 | TIM-3 | Huntington'sPNH | ||
| ADI-2736 | ADI-2736 | Preclinical | 2 | PD-1 | Ewing Sarcoma | ||
| Datoglumide | ADI-5772 | Phase 2 | 1 | Tau | Bladder Ca |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)